JOHN R MOORE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN R MOORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN R MOORE. JOHN R MOORE is a VP AND GENERAL COUNSEL in ARRAY BIOPHARMA INC ($ARRY) and a VP, General Counsel in ARRAY BIOPHARMA INC ($ARRY) and a Director in Nivalis Therapeutics, Inc. ($NVLS).
Address: 3200 WALNUT STREET BOULDER 80301 CO
Companies in which JOHN R MOORE is an Insider
ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN R MOORE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 14 2016
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARRAY BIOPHARMA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN R MOORE: VP, General Counsel, VP AND GENERAL COUNSEL
Holdings: 46,472 shares
Current Value: $489,350
Latest Transaction: Apr 04 2017
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN R MOORE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | M | 0.00 | 6,718 | 0 | 20,157 | |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Payment of Exercise | F | 8.94 | 4,408 | 39,408 | 42,064 | 46.5 K to 42.1 K (-9.49 %) |
| Apr 04 2017 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Buy | M | 0.00 | 6,718 | 0 | 46,472 | 39.8 K to 46.5 K (+16.90 %) |
| Dec 29 2016 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | A | 8.79 | 131,250 | 1,153,688 | 131,250 | |
| Dec 29 2016 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | A | 0.00 | 21,875 | 0 | 21,875 | |
| Sep 14 2016 | NVLS | Nivalis Therapeuti ... | MOORE JOHN R | Director | Option Exercise | A | 7.77 | 12,300 | 95,571 | 12,300 | |
| Apr 05 2016 | ARRY | ARRAY BIOPHARMA IN ... | MOORE JOHN R | VP, General Counsel | Option Exercise | A | 3.00 | 161,250 | 483,750 | 161,250 |